Published in AIDS Weekly, August 15th, 2005
The sum is a $12 million increase over the 2005 level, and $6 million above the amount approved by the House for FY 06. $4 million of the increase is designated for the International Partnership for Microbicides, with the remainder going to other USAID-supported nongovernment organizations conducting trials of several promising microbicide candidates. USAID is currently funding four Phase III clinical trials to study the effectiveness...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.